References
- Sharma S, Zapatero-Rodriguez J, O’Kennedy R. Prostate cancer diagnostics: Clinical challenges and the ongoing need for disruptive and effective diagnostic tools. Biotechnology Advances. 2017;35(2):135-49. DOI: 10.1016/j.biotechadv.2016.11.009
- Hanahan D. Hallmarks of cancer: new dimensions. Cancer discovery. 2022;12(1):31-46. DOI: 10.1158/2159-8290.CD-21-1059
- Sfanos KS, De Marzo AM. Prostate cancer and inflammation: the evidence. Histopathology. 2012;60(1):199-215. DOI: 10.1111/j.1365-2559.2011.04033.x
- Kurowska P, Mlyczyńska E, Dawid M, Jurek M, Klimczyk D, Dupont J, et al. Vaspin (SERPINA12) expression and function in endocrine cells. Cells. 2021;10(7):1710. DOI: 10.3390/cells10071710
- Zhang P, Wang G, Gui Y, Guo Z, Ren R, Sun Y, et al. Serum vaspin as a predictor of severity and prognosis in acute ischemic stroke patients. Nutritional Neuroscience. 2022;25(4):737-45. DOI: 10.1080/1028415X.2020.1806191
- Agarwal S, Desai S. Vaspin and its relation to cancer. World Academy of Sciences Journal. 2021;3(6):1-6. DOI: 10.3892/wasj.2021.129
- Si H, Zhang Y, Song Y, Li L. Overexpression of adrenomedullin protects mesenchymal stem cells against hypoxia and serum deprivationinduced apoptosis via the Akt/GSK3β and Bcl2 signaling pathways. International journal of molecular medicine. 2018;41(6):3342-52. DOI: 10.3892/ijmm.2018.3533
- Treeck O, Buechler C, Ortmann O. Chemerin and cancer. International journal of molecular sciences. 2019;20(15):3750. DOI: 10.3390/ijms20153750
- Groblewska M, Litman-Zawadzka A, Mroczko B. The role of selected chemokines and their receptors in the development of gliomas. International journal of molecular sciences. 2020;21(10):3704. DOI: 10.3390/ijms21103704
- Jaikanth C, Gurumurthy P, Cherian K, Indhumathi T. Emergence of omentin as a pleiotropic adipocytokine. Experimental and clinical endocrinology & diabetes. 2013;121(07):377-83. DOI: 10.1055/s-0033-1345123
- Uyeturk U, Sarıcı H, Kın Tekce B, Eroglu M, Kemahlı E, Uyeturk U, et al. Serum omentin level in patients with prostate cancer. Medical oncology. 2014;31:1-5. DOI: 10.1007/s12032-014-0923-6
- Li B. Effects of NFκB Inhibition on Macrophage-adipocytes-prostate Cancer Cell Crosstalk: University of Sheffield; 2021.
- Wang W, Nag SA, Zhang R. Targeting the NFκB signaling pathways for breast cancer prevention and therapy. Current medicinal chemistry. 2015;22(2):264-89. DOI: 10.2174/092986732166614 1106124315
- Davidsson S, Carlsson J, Greenberg L, Wijkander J, Söderquist B, Erlandsson A. Cutibacterium acnes induces the expression of immunosuppressive genes in macrophages and is associated with an increase of regulatory T-cells in prostate cancer. Microbiology spectrum. 2021;9(3):e01497-21. DOI: 10.1128/spectrum.01497-21
- Kumar A, Khani AT, Ortiz AS, Swaminathan S. GM-CSF: A double-edged sword in cancer immunotherapy. Frontiers in Immunology. 2022;13. DOI: 10.3389/fimmu.2022.901277
- Rourke J, Dranse H, Sinal C. Towards an integrative approach to understanding the role of chemerin in human health and disease. Obesity Reviews. 2013;14(3):245-62. DOI: 10.1111/obr.12009
- Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nature reviews immunology. 2011;11(2):85-97. DOI: 10.1038/nri2921
- Kaur J, Adya R, Tan BK, Chen J, Randeva HS. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochemical and biophysical research communications. 2010;391(4):1762-8. DOI: 10.1016/j.bbrc.2009.12.150
- Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, et al. Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer research. 2008;68(1):329-37. DOI: 10.1158/0008-5472. CAN-07-2946
- Booth A, Magnuson A, Fouts J, Foster M. Adipose tissue, obesity and adipokines: role in cancer promotion. Hormone molecular biology and clinical investigation. 2015;21(1):57-74. DOI: 10.1515/hmbci-2014-0037
- Erdogan S, Yilmaz FM, Yazici O, Yozgat A, Sezer S, Ozdemir N, et al. Inflammation and chemerin in colorectal cancer. Tumor Biology. 2016;37:6337-42. DOI: 10.1007/s13277-015-4483-y
- Wang C, Wu WK, Liu X, To K-F, Chen GG, Yu J, et al. Increased serum chemerin level promotes cellular invasiveness in gastric cancer: a clinical and experimental study. Peptides. 2014;51:131-8. DOI: 10.1016/j.peptides.2013.10.009
- Fazeli MS, Dashti H, Akbarzadeh S, Assadi M, Aminian A, Keramati MR, et al. Circulating levels of novel adipocytokines in patients with colorectal cancer. Cytokine. 2013;62(1):81-5. DOI: 10.1016/j. cyto.2013.02.012
- Wong RS. Apoptosis in cancer: from pathogenesis to treatment. Journal of experimental & clinical cancer research. 2011;30(1):1-14. DOI: 10.1186/1756-9966-30-87
- Danielsen SA, Eide PW, Nesbakken A, Guren T, Leithe E, Lothe RA. Portrait of the PI3K/AKT pathway in colorectal cancer. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2015;1855(1):104-21. DOI: 10.1016/j.bbcan.2014.09.008
- Zhao X, Zhang Y, Deng L, Wang Y, Li Y, Chen M. The association between Chinese patients’ elevated omentin-1 levels, their clinicopathological features, and the risk of colorectal cancer. International journal of clinical and experimental pathology. 2019;12(6):2264.
- Washimi K, Yokose T, Yamashita M, Kageyama T, Suzuki K, Yoshihara M, et al. Specific expression of human intelectin-1 in malignant pleural mesothelioma and gastrointestinal goblet cells. PLoS One. 2012;7(7):e39889. DOI: 10.1371/journal.pone.0039889
- Karabulut S, Afsar CU, Karabulut M, Alis H, Bozkurt MA, Aydogan F, et al. Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma. BBA clinical. 2016;6:138-42. DOI: 10.1016/j.bbacli.2016.10.002
- Zhou L, He W, Wang W, Zhou D. Altered circulating levels of adipokine omentin-1 in patients with prostate cancer. OncoTargets and therapy. 2019;12:3313. DOI: 10.2147/OTT. S197507
- Fryczkowski M, Bułdak R, Hejmo T, Kukla M, Żwirska-Korczala K. Circulating levels of omentin, leptin, VEGF, and HGF and their clinical relevance with PSA marker in prostate cancer. Disease markers. 2018;2018. DOI: 10.1155/2018/3852401
- Zhang Y-Y, Zhou L-M. Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells. European journal of pharmacology. 2013;698(1-3):137-44. DOI: 10.1016/j. ejphar.2012.11.016
- Ji H, Wan L, Zhang Q, Chen M, Zhao X. The effect of omentin-1 on the proliferation and apoptosis of colon cancer stem cells and the potential mechanism. J buon. 2019;24(1):91-8.
- Zhang Y, Zhao X, Chen M. Autocrine action of adipokine omentin1 in the SW480 colon cancer cell line. Oncology Letters. 2020;19(1):892-8. DOI: 10.3892/ol.2019.11131
- Borowski A, Siemińska L. Serum omentin levels in patients with prostate cancer and associations with sex steroids and metabolic syndrome. Journal of Clinical Medicine. 2020;9(4):1179. DOI: 10.3390/jcm9041179
- Lin S, Li X, Zhang J, Zhang Y. Omentin-1: Protective impact on ischemic stroke via ameliorating atherosclerosis. Clinica Chimica Acta. 2021;517:31-40. DOI: 10.1016/j.cca.2021.02.004
- Pin E, Stratton S, Belluco C, Liotta L, Nagle R, Hodge KA, et al. A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray. Molecular Oncology. 2016;10(10):1585-94. DOI: 10.1016/j. molonc.2016.09.007
- Neveu B, Moreel X, Deschênes-Rompré M-P, Bergeron A, LaRue H, Ayari C, et al. IL-8 secretion in primary cultures of prostate cells is associated with prostate cancer aggressiveness. Research and reports in urology. 2014:27-34. DOI: 10.2147/RRU.S58643
- Chaiswing L, Weiss HL, Jayswal RD, Clair DKS, Kyprianou N. Profiles of radioresistance mechanisms in prostate cancer. Critical Reviews™ in Oncogenesis. 2018;23(1-2). DOI: 10.1615/CritRevOncog.2018025946
- Touvier M, Fezeu L, Ahluwalia N, Julia C, Charnaux N, Sutton A, et al. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study. American journal of epidemiology. 2013;177(1):3-13. DOI: 10.1093/aje/kws359
- Yencilek F, Yildirim A, Yilmaz SG, Altinkilic EM, Dalan AB, Bastug Y, et al. Investigation of interleukin-1β polymorphisms in prostate cancer. Anticancer Research. 2015;35(11):6057-61.
- Thibodeau S, French A, McDonnell S, Cheville J, Middha S, Tillmans L, et al. Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set. Nature communications. 2015;6(1):8653. DOI: 10.1038/ncomms9653
- Park M-J, Hyun M-H, Yang J-P, Yoon J-M, Park S. Effects of the interleukin-1β-511 C/T gene polymorphism on the risk of gastric cancer in the context of the relationship between race and H. pylori infection: a meta-analysis of 20,000 subjects. Molecular biology reports. 2015;42:119-34. DOI: 10.1007/s11033-014-3748-7
- Wang J, Shi Y, Wang G, Dong S, Yang D, Zuo X. The association between interleukin-1 polymorphisms and their protein expression in Chinese Han patients with breast cancer. Molecular Genetics & Genomic Medicine. 2019;7(8):e804. DOI: 10.1002/mgg3.804
- Urquidi V, Kim J, Chang M, Dai Y, Rosser CJ, Goodison S. CCL18 in a multiplex urine-based assay for the detection of bladder cancer. PLoS One. 2012;7(5):e37797. DOI: 10.1371/journal. pone.0037797
- Sun Z, Du C, Xu P, Miao C. Surgical trauma-induced CCL18 promotes recruitment of regulatory T cells and colon cancer progression. Journal of cellular physiology. 2019;234(4):4608-16. DOI: 10.1002/jcp.27245
- Wang L, Wang Y-x, Zhang D-z, Fang X-j, Sun P-s, Xue H-c. Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway. Biomedicine & Pharmacotherapy. 2016;78:301-7. DOI: 10.1016/j.biopha.2016.01.028
- Wang Q, Tang Y, Yu H, Yin Q, Li M, Shi L, et al. CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway. Molecular Carcinogenesis. 2016;55(11):1688-99.. DOI: 10.1002/mc.22419
- Hou X, Zhang Y, Qiao H. CCL18 promotes the invasion and migration of gastric cancer cells via ERK1/2/NF-κB signaling pathway. Tumor Biology. 2016;37:641-51. DOI: 10.1007/s13277-015-3825-0
- Meng F, Li W, Li C, Gao Z, Guo K, Song S. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma. International journal of oncology. 2015;46(3):1109-20. DOI: 10.3892/ijo.2014.2794
- Su Y, Zhou Y, Sun Y-j, Wang Y-L, Yin J-y, Huang Y-j, et al. Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1. Journal of Molecular Medicine. 2019;97:49-61. DOI: 10.1007/s00109-018-1711-0
- She L, Qin Y, Wang J, Liu C, Zhu G, Li G, et al. Tumor-associated macrophages derived CCL18 promotes metastasis in squamous cell carcinoma of the head and neck. Cancer cell international. 2018;18(1):1-14. DOI: 10.1186/s12935-018-0620-1
- Schmid S, Csanadi A, Kozhuharov N, Tchudjin M, Kayser C, Rawluk J, et al. CC-chemokine ligand 18 is an independent prognostic marker in lymph node-positive non-small cell lung cancer. Anticancer Research. 2018;38(7):3913-8. DOI: 10.21873/anticanres.12676
- Chen G, Liang Y-x, Zhu J-g, Fu X, Chen Y-f, Mo R-j, et al. CC chemokine ligand 18 correlates with malignant progression of prostate cancer. BioMed research international. 2014;2014. . DOI: 10.1155/2014/230183
- Hong I-S. Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types. Experimental & molecular medicine. 2016;48(7):e242-e. DOI: 10.1038/emm.2016.64
- Rho CR, Park M-y, Kang S. Effects of granulocyte-macrophage colony-stimulating (GM-CSF) factor on corneal epithelial cells in corneal wound healing model. PLoS One. 2015;10(9):e0138020. DOI: 10.1371/journal.pone.0138020
- Urdinguio RG, Fernandez AF, Moncada-Pazos A, Huidobro C, Rodriguez RM, Ferrero C, et al. Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal TumorsAntitumor Activity of GM-CSF in Colorectal Tumors. Cancer research. 2013;73(1):395-405. DOI: 10.1158/0008-5472.CAN-12-0806
- Ardekani MTF, Malekzadeh M, Hosseini SV, Bordbar E, Doroudchi M, Ghaderi A. Evaluation of pre-treatment serum levels of IL-7 and GM-CSF in colorectal cancer patients. International journal of molecular and cellular medicine. 2014;3(1):27.
- Zemanová M, Staňková B, Ušiakova Z, Tvrzická E, Pazdro A, Petruželka L, et al. Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: A pilot study. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2014;20:2351. DOI: 10.12659/MSM.891088
- Gartung A, Yang J, Sukhatme VP, Bielenberg DR, Fernandes D, Chang J, et al. Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor. Proceedings of the National Academy of Sciences. 2019;116(5):1698-703. DOI: 10.1073/pnas.1803999116
- Haak VM, Huang S, Panigrahy D. Debris-stimulated tumor growth: a Pandora’s box? Cancer and Metastasis Reviews. 2021:1-11. DOI: 10.1007/s10555-021-09998-8
- Mendoza-Reinoso V, Baek DY, Kurutz A, Rubin JR, Koh AJ, McCauley LK, et al. Unique pro-inflammatory response of macrophages during apoptotic cancer cell clearance. Cells. 2020;9(2):429. DOI: 10.3390/cells9020429
- Morana O, Wood W, Gregory CD. The apoptosis paradox in cancer. International Journal of Molecular Sciences. 2022;23(3):1328. DOI: 10.3390/ijms23031328
- Middleton JD, Fehlman J, Sivakumar S, Stover DG, Hai T. Stress-inducible gene Atf3 dictates a dichotomous macrophage activity in chemotherapy-enhanced lung colonization. International journal of molecular sciences. 2021;22(14):7356. DOI: 10.3390/ijms22147356
- Peng S, Fu Y. FYN: emerging biological roles and potential therapeutic targets in cancer. Journal of Translational Medicine. 2023;21(1):84. DOI: 10.1186/s12967-023-03930-0
- Kaplanov I, Carmi Y, Kornetsky R, Shemesh A, Shurin GV, Shurin MR, et al. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes withanti-PD-1 for tumor abrogation. Proceedings of the National Academy of Sciences. 2019;116(4):1361-9. DOI: 10.1073/pnas.1812266115
- Ghahartars M, Abtahi S, Zeinali Z, Fattahi MJ, Ghaderi A. Investigation of TNF-α and IL-6 levels in the sera of non-melanoma skin cancer patients. Iranian biomedical journal. 2021;25(2):88. DOI: 10.29252/ibj.25.2.88
- Fletcher R, Tong J, Risnik D, Leibowitz BJ, Wang Y-J, Concha-Benavente F, et al. Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis. Oncogene. 2021;40(11):2035-50. DOI: 10.1038/s41388-021-01687-8